Ozempic, Wegovy to carry FDA warning over rare risk of vision loss
Popular weight-loss and diabetes drugs, including Ozempic and Wegovy, will carry a new warning about a rare eye condition that can cause significant and sometimes permanent vision loss, the US Food and Drug Administration (FDA) announced on Monday. The warning will be added to the labels of all GLP-1 drugs, a class of medicines used […]
Ozempic, Wegovy to carry FDA warning over rare risk of vision loss Read More »









